Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.
Journal: Nature communications
Published: November 05, 2025
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044).
Journal: Gynecologic oncology
Published: December 16, 2024
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 25, 2024
Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma.
Journal: Advances in radiation oncology
Published: February 06, 2022
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 20, 2020
Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Journal: Gynecologic oncology
Published: July 25, 2019
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
Journal: American journal of obstetrics and gynecology
Published: June 29, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: April 06, 2017
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: September 21, 2015
Cost-utility of routine endometrial evaluation before le fort colpocleisis.
Journal: Female pelvic medicine & reconstructive surgery
Published: April 26, 2014
Key concepts in management of vulvar cancer.
Journal: Best practice & research. Clinical obstetrics & gynaecology
Published: September 06, 2013
Last Updated: 09/26/2026